Procyon Corp. is a holding company, which engages in the development and marketing of proprietary medical products. Its products include AMERX, AMERIGEL, HELIX3 Bioactive Collagen, and EXTREMIT-EASE Compression Garment. The company was founded on March 19, 1987 and is headquartered in Clearwater, FL.
Company profile
Ticker
PCYN
Exchange
Website
CEO
Justice Wolfe Anderson
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
SEC CIK
IRS number
368732690
PCYN stock data
Calendar
16 May 22
2 Jul 22
30 Jun 23
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 21 | Jun 20 | Jun 19 | Jun 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar 22 | Foundation Speer | Common Stock | Sell | Dispose S | No | No | 0 | 40,000 | 0 | 1,460,000 |
7 Feb 22 | Foundation Speer | Common Stock | Sell | Dispose S | No | No | 0 | 15,000 | 0 | 1,500,000 |
6 Dec 21 | Foundation Speer | Common Stock | Sell | Dispose S | No | No | 0 | 25,000 | 0 | 1,515,000 |
30 Jun 21 | Justice Wolfe Anderson | Stock Option Common Stock | Grant | Acquire A | No | No | 0.373 | 25,000 | 9.33K | 25,000 |
30 Jun 21 | James Brian Anderson | Stock Option Common Stock | Grant | Acquire A | No | No | 0.373 | 25,000 | 9.33K | 25,000 |
30 Jun 17 | Justice Wolfe Anderson | Stock Option Common Stock | Grant | Acquire A | No | No | 0.19 | 25,000 | 4.75K | 25,000 |
30 Jun 16 | Justice Wolfe Anderson | Stock Option Common Stock | Grant | Acquire A | No | No | 0.15 | 40,000 | 6K | 40,000 |
Institutional ownership, Q1 2021
19.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0 |
Total shares | 1.56M |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Foundation Speer | 1.56M | $0 |
Financial report summary
?Management Discussion
- Revenues. Revenues decreased by $1.5 million, or 17%, from $8.8 million for the three months ended March 31, 2021 to $7.3 million for the three months ended March 31, 2022. The decrease was mainly driven by a contract reduction from our largest customer (as first disclosed in the Q3 2020 Form 10-Q), which was effective in Q2 2021. The revenue impact of this contract reduction was $0.7 million. Additionally, revenue was adversely impacted by customer contracts renewals at lower values and churn coupled with the end of life of several legacy products that began during 2020. These declines were offset by new customers added in 2021 and 2022 in our Threat Detection and email security businesses.
- During the second quarter of 2020, the Company released two new products, Cyren Inbox Security and Threat InDepth. Since these product launches, the Company has signed numerous new customer contracts representing over $3.3 million in estimated revenue over the lives of the contracts, but due to the timing, duration and ratable nature of the contracts, there was not a material amount of revenue recognized for the three months ended March 31, 2022 or March 31, 2021.
- Cost of Revenues. Cost of revenues for the three months ended March 31, 2022 was consistent with cost of revenues for the three months ended March 31, 2021. For the three months ended March 31, 2022, cost of revenues represented 53% of revenue, compared to 43% during the same period in the prior year, and accordingly, gross margins for the period were 47% for the three months ended March 31, 2022 compared to 57% for the same period in the prior year, primarily due to the decline in revenue. Payroll and related expenses decreased by $0.1 million or 1% primarily due to a decline in headcount from 36 employees as of March 31, 2021, compared to 31 as of March 31, 2022. Offsetting some of this decrease was an increase of $0.1 million in share-based compensation related to new equity awards issued in the period ending March 31, 2022. Other costs of revenue expenses increased by $0.1 million or 3% primarily due to an increase in costs associated with maintaining our datacenters.
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
acquired, Additionally, alternative, Alternatively, assist, automatically, began, book, case, charge, collateralized, conflict, cyberterrorism, datacenter, discontent, displacement, duration, economy, environment, equivalent, escalation, EU, Europe, eventually, fleeing, float, fractional, furniture, goodwill, hired, humanitarian, impaired, impairment, inflation, interruption, lessor, located, longer, military, minimal, modification, multiple, nearest, par, party, phase, popular, precise, premise, privacy, proceed, promotion, protracted, qualitative, quantitative, range, ratio, region, repaid, Restated, retroactively, ROU, Russia, Russian, salary, social, source, step, strategy, sustained, test, tested, testing, thirty, turn, twenty, Ukraine, unaffiliated, unforeseen, vacation, volatility, wider
Removed:
agreed, alleged, amend, antimalware, application, applied, appointed, attributable, Aviv, bad, blackout, breaching, built, Claim, claimed, combat, commitment, comparative, complaint, contended, controlling, corroborated, court, covering, create, cure, cybersecurity, database, Defense, delete, denied, direction, discounted, disease, dismissed, District, enriched, entirety, epidemic, examine, final, fully, Germany, gradually, half, health, hierarchy, highly, Iceland, identification, implemented, implicit, indemnify, index, infringing, initially, injunctive, issuable, judgment, jurisdiction, launch, lawsuit, level, mediation, mediator, method, misappropriated, mitigating, modified, monetary, negatively, negotiating, newest, observable, October, operational, ordering, outbreak, package, partial, partnership, personal, piggyback, platform, policy, post, postpone, predicted, prejudice, Pretrial, Purpose, quoted, reached, readily, receipt, recommendation, recording, refinance, relief, remeasurement, removing, renegotiate, renewal, resale, respiratory, restructure, restructuring, retrospective, scheduled, seek, settlement, Simplifying, situation, SOC, sought, spread, strategic, structure, subsequent, Tel, terminated, Topic, transition, ultimate, unjustly, utilize, utilizing, variable, Warburg
Financial reports
Current reports
8-K
Cyren Announces Divestment to Enable Focus on Strategic Growth Opportunities
7 Jun 22
8-K
Cyren Announces First Quarter 2022 Financial Results
17 May 22
8-K
Cyren Announces Fourth Quarter and Full Year 2021 Financial Results
24 Mar 22
8-K
Other Events
25 Feb 22
8-K
Cyren Announces $12 Million Private Placement Priced At-the-Market
13 Feb 22
8-K
Results of Operations and Financial Condition
10 Feb 22
8-K
Cyren Announces Reverse Share Split
9 Feb 22
8-K
Cyren Announces Repayment of Convertible Notes
9 Dec 21
8-K
Cyren Announces Third Quarter 2021 Financial Results
15 Nov 21
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6 Oct 21
Registration and prospectus
424B3
Prospectus supplement
30 Mar 22
S-3/A
Shelf registration (amended)
24 Mar 22
D
$12M in equity / options / securities to be acquired, sold $12M, 3 investors
15 Feb 22
424B3
Prospectus supplement
8 Oct 21
S-3
Shelf registration
1 Oct 21
D
$10.19M in equity / options / securities to be acquired, sold $10.19M, 6 investors
30 Sep 21
424B5
Prospectus supplement for primary offering
16 Feb 21
424B3
Prospectus supplement
26 May 20
S-8
Registration of securities for employees
14 May 20
Other
EFFECT
Notice of effectiveness
31 Mar 22
CORRESP
Correspondence with SEC
28 Mar 22
CORRESP
Correspondence with SEC
23 Mar 22
UPLOAD
Letter from SEC
27 Feb 22
EFFECT
Notice of effectiveness
8 Oct 21
CORRESP
Correspondence with SEC
4 Oct 21
UPLOAD
Letter from SEC
4 Oct 21
EFFECT
Notice of effectiveness
27 May 20
CORRESP
Correspondence with SEC
20 May 20
UPLOAD
Letter from SEC
17 May 20
Ownership
4
CYREN / Michael Fleck ownership change
23 Jun 22
4
CYREN / Michael Tamir ownership change
28 Mar 22
4
CYREN / Eva Lilias Markowitz ownership change
28 Mar 22
4
CYREN / Michael Fleck ownership change
28 Mar 22
4
CYREN / Bruce Harold Johnson ownership change
28 Mar 22
SC 13G/A
CYREN / CVI Investments ownership change
14 Feb 22
SC 13G/A
CYREN / Yelin Lapidot Holdings Management ownership change
7 Feb 22
3
CYREN / Brian Joseph Dunn ownership change
20 Dec 21
4
CYREN / Isaac Dvir ownership change
24 Sep 21
3
CYREN / Isaac Dvir ownership change
24 Sep 21